Cargando…

In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer’s Disease: A (18)F-Florzolotau Study

Purpose: (18)F-Florzolotau is a novel second-generation tau radiotracer that shows higher binding affinity and selectivity and no off-target binding. The proportion loss of functional connectivity strength (PLFCS) is a new indicator for representing brain functional connectivity (FC) alteration. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ju, Zizhao, Li, Zhuoyuan, Lu, Jiaying, Jiao, Fangyang, Lin, Huamei, Bao, Weiqi, Li, Ming, Wu, Ping, Guan, Yihui, Zhao, Qianhua, Zhang, Huiwei, Jiang, Jiehui, Zuo, Chuantao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599090/ https://www.ncbi.nlm.nih.gov/pubmed/36291289 http://dx.doi.org/10.3390/brainsci12101355

Ejemplares similares

Improved interpretation of (18)F-florzolotau PET in progressive supranuclear palsy using a normalization-free deep-learning classifier
por: Lu, Jiaying, et al.
Publicado: (2023)

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment
por: Jiao, Fangyang, et al.
Publicado: (2023)

Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [(18)F]-APN-1607 Study
por: Zhang, Huiwei, et al.
Publicado: (2021)

Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [(18)F]Florzolotau PET imaging and subtype/stage inference algorithm
por: Hong, Jimin, et al.
Publicado: (2023)

(18)F-Florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy
por: Liu, Feng-Tao, et al.
Publicado: (2023)

Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects
por: Miyamoto, Masaomi, et al.
Publicado: (2023)

Radiomics: a novel feature extraction method for brain neuron degeneration disease using (18)F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment
por: Li, Yupeng, et al.
Publicado: (2019)

Brain Network and Abnormal Hemispheric Asymmetry Analyses to Explore the Marginal Differences in Glucose Metabolic Distributions Among Alzheimer's Disease, Parkinson's Disease Dementia, and Lewy Body Dementia
por: Chen, Danyan, et al.
Publicado: (2019)

Associations of [(18)F]-APN-1607 Tau PET Binding in the Brain of Alzheimer’s Disease Patients With Cognition and Glucose Metabolism
por: Lu, Jiaying, et al.
Publicado: (2020)

Optimized Cingulate Island Sign in Discriminating Dementia With Lewy Bodies From Alzheimer Disease
por: Ge, Jingjie, et al.
Publicado: (2023)

Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
por: Lin, Huan-Chun, et al.
Publicado: (2023)

Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints
por: Lu, Jiaying, et al.
Publicado: (2023)

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
por: Zhou, Hucheng, et al.
Publicado: (2019)

The Parkinson's Disease Progression Neuroimaging Initiative
por: Zhu, Shiyi, et al.
Publicado: (2021)

The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s disease
por: Lu, Jiaying, et al.
Publicado: (2023)

Misery Perfusion and Tau Deposition in Atherosclerotic Major Cerebral Artery Disease: A (18)F-Florzolotau Positron Emission Tomography Study
por: Yamauchi, Hiroshi, et al.
Publicado: (2022)

Validation of abnormal glucose metabolism associated with Parkinson’s disease in Chinese participants based on 18F-fluorodeoxyglucose positron emission tomography imaging
por: Jin, Rongbing, et al.
Publicado: (2018)

Glucose Metabolic Brain Network Differences between Chinese Patients with Lewy Body Dementia and Healthy Control
por: Chen, Danyan, et al.
Publicado: (2018)

Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images
por: Shen, Ting, et al.
Publicado: (2019)

Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study
por: Ge, Jingjie, et al.
Publicado: (2020)

Distinct cerebral (18)F-FDG PET metabolic patterns in anti-N-methyl-D-aspartate receptor encephalitis patients with different trigger factors
por: Ge, Jingjie, et al.
Publicado: (2021)

Dopamine transporter changes after unilateral deep brain stimulation in progressive Parkinson’s disease: a case report
por: Zhang, Huiwei, et al.
Publicado: (2014)

PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research
por: Bao, Weiqi, et al.
Publicado: (2021)

Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer’s dementia
por: Wang, Min, et al.
Publicado: (2020)

Neuropeptide Y Plays an Important Role in the Relationship Between Brain Glucose Metabolism and Brown Adipose Tissue Activity in Healthy Adults: A PET/CT Study
por: Zhang, Qiongyue, et al.
Publicado: (2021)

Frequency-Dependent Relationship Between Resting-State fMRI and Glucose Metabolism in the Elderly
por: Jiao, Fangyang, et al.
Publicado: (2019)

PET Imaging for Dynamically Monitoring Neuroinflammation in APP/PS1 Mouse Model Using [(18)F]DPA714
por: Hu, Wei, et al.
Publicado: (2020)

Individual Proportion Loss of Functional Connectivity Strength: A Novel Individual Functional Connectivity Biomarker for Subjective Cognitive Decline Populations
por: Li, Zhuoyuan, et al.
Publicado: (2023)

Brain Functional and Structural Signatures in Parkinson’s Disease
por: Liu, Chunhua, et al.
Publicado: (2020)

Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning
por: Zhao, Yu, et al.
Publicado: (2022)

A Fully Automatic Framework for Parkinson’s Disease Diagnosis by Multi-Modality Images
por: Xu, Jiahang, et al.
Publicado: (2019)

The nucleus accumbens functional connectivity in patients with insomnia using resting-state fMRI
por: Li, Fangjie, et al.
Publicado: (2023)

Using Deep Learning Radiomics to Distinguish Cognitively Normal Adults at Risk of Alzheimer’s Disease From Normal Control: An Exploratory Study Based on Structural MRI
por: Jiang, Jiehui, et al.
Publicado: (2022)

A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment
por: Wang, Min, et al.
Publicado: (2020)

Study of the Influence of Age in (18)F-FDG PET Images Using a Data-Driven Approach and Its Evaluation in Alzheimer's Disease
por: Jiang, Jiehui, et al.
Publicado: (2018)

Effects of long-term salicylate administration on synaptic ultrastructure and metabolic activity in the rat CNS
por: Yi, Bin, et al.
Publicado: (2016)

International consensus on the use of tau PET imaging agent (18)F-flortaucipir in Alzheimer’s disease
por: Tian, Mei, et al.
Publicado: (2022)

Combining PET with MRI to improve predictions of progression from mild cognitive impairment to Alzheimer’s disease: an exploratory radiomic analysis study
por: Yang, Fan, et al.
Publicado: (2022)

Abnormal Times and Their Burdens
Publicado: (1916)

Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology
por: Zhang, Shengnan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b7pdltk15u4upsmthlv9g8k6pl